Pillar VC

We’re excited to share a new multi-year collaboration with @TakedaPharma, building on the success of our first engagement. Under the agreement, Nabla will receive double-digit millions in upfront and research payments and is eligible for success-based payments exceeding $1 billion. The partnership deploys Nabla’s AI-driven JAM platform across Takeda’s early-stage programs to include de novo design of antibodies in parallel for multiple targets, multispecifics, challenging targets, and other custom therapeutics. Read more below

Introducing Latent-X — our all-atom frontier AI model for protein binder design. State-of-the-art lab performance, widely accessible via the Latent Labs Platform. Free tier: platform.latentlabs.com Blog: latentlabs.com/latent-x/ Technical report: tinyurl.com/latent-X

‘Latent Labs launches web-based AI model to democratize protein design.’ Thank you @TechCrunch and @MTemkin for the coverage. Read the full story: tinyurl.com/Latent-X-TechC…

Latent Labs launches web-based AI model to democratize protein design | TechCrunch techcrunch.com/2025/07/21/lat…

🚨 The 2025 State of Engineering Management report is here 🚨 We surveyed more than 600 engineering professionals across the globe to learn how AI is reshaping software development. 🧠 Here's what we found → ow.ly/fMvr50WmiHC

OpenHands is live on TerminalBench and gets 41.3% with claude-4-sonnet, 6 points better than Claude Code! If you want to use an agent that can use the terminal, in your terminal -- try out the OpenHands CLI.

🚀 Today, we're excited to introduce Team Pulse—the new command center helping engineering managers predict delays, address blockers, and keep teams productive. Gain clarity and control, one pulse check at a time:ow.ly/5pZ750Wg8OL #engineeringmanagement #engineering

I just talked to @parker_mckee (@pillar_vc) about China's influence on global AI implementation. "The rate at which these models become obsolete is borderline comedically fast...I'm less worried about a third world country getting stuck with a specific regime's model."

Abridge raises $300M Series E funding round led by @a16z, and joined by @khoslaventures to pioneer a new paradigm of care with intelligence at the point of conversation. 🚀 @DavidGeorge83, 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝗣𝗮𝗿𝘁𝗻𝗲𝗿 𝗮𝘁 𝗔𝗻𝗱𝗿𝗲𝗲𝘀𝘀𝗲𝗻 𝗛𝗼𝗿𝗼𝘄𝗶𝘁𝘇: “Abridge eliminates inefficiencies at their source, directly in the clinical conversation, with a platform that has demonstrated tremendous traction and impact in the market. This is a company with truly rare ingredients: world-class clinical and technical leadership, deep scientific credibility, and AI technology that is years ahead of the field. Abridge has both the vision and velocity to create lasting, systemic change, and we are thrilled to be part of their journey.” Abridge is now deployed at 𝟭𝟱𝟬 𝗲𝗻𝘁𝗲𝗿𝗽𝗿𝗶𝘀𝗲 𝗵𝗲𝗮𝗹𝘁𝗵 𝘀𝘆𝘀𝘁𝗲𝗺𝘀 and will support more than 𝟱𝟬 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻𝘀 this year alone, across specialties, care settings from outpatient to ERs to inpatient workflows—all with 𝗰𝗹𝗶𝗻𝗶𝗰𝗶𝗮𝗻 𝗿𝗲𝘁𝗲𝗻𝘁𝗶𝗼𝗻 𝗿𝗮𝘁𝗲𝘀 𝗼𝗳 𝗼𝘃𝗲𝗿 𝟵𝟬%. This is a new standard for delivering impact at scale for enterprise-grade AI in healthcare, and it’s just the beginning. Read more here: abridge.com/blog/series-e

🎉 Jellyfish has been a consistent G2 Software Development Analytics Tools grid leader for three years in a row! No surprise considering: ⭐ 97% of users gave Jellyfish a 4- or 5-star rating 🙋 90% would recommend Jellyfish to others Learn more: ow.ly/HQ3O50WfqCp

Congratulations to Pillar VC Founding Pillars Jason Robins, Corey Thomas, Andrew Beck, Niraj Shah, and Jeremy Allaire on being named to the @BostonGlobe's 2025 Tech Power Players list!

🏆𝗔𝘄𝗮𝗿𝗱: @CNBC 𝗡𝗮𝗺𝗲𝘀 𝗔𝗯𝗿𝗶𝗱𝗴𝗲 𝘁𝗼 𝗗𝗶𝘀𝗿𝘂𝗽𝘁𝗼𝗿 𝟱𝟬 𝗟𝗶𝘀𝘁 𝗳𝗼𝗿 𝗺𝗼𝘀𝘁 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗰𝗵𝗮𝗻𝗴𝗶𝗻𝗴 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱 𝘄𝗶𝘁𝗵 𝗔𝗜 By 2030, the U.S. will have a shortage of 100,000 doctors because of burdensome clerical work. Abridge empowers clinicians to focus more fully on patients by transforming and enhancing clinical documentation workflows. Clinicians tell us every day how Abridge has renewed their love of practicing medicine. Because of Abridge, ambient AI will soon be ubiquitous in healthcare and clinician burnout from administrative work will be a thing of the past. ❤️‍🩹

Circle is now officially a public company, listed on the @NYSE under $CRCL. With @USDC, EURC, Circle Payments Network & more, we're pushing forward a future of frictionless value exchange. We are not just building financial products. We are building the money layer of the internet. To everyone who has contributed to this moment, thank you.

I am incredibly proud and thrilled to share that @circle is now a public company listed on the New York Stock Exchange under $CRCL! 12 years ago we set out to build a company that could help remake the global economic system by re-imagining and re-building it from the ground up natively on the internet.  Our mission – to raise global economic prosperity through the frictionless exchange of value – has animated our work ever since. When we founded the company, I told every employee and every investor that this was a multi-decade opportunity, and that I sought to build a deeply lasting internet technology platform.  Now, just over a decade in, we are just starting to realize our early vision. Our transformation into being a public company is a significant and powerful milestone – the world is ready to start upgrading and moving to the internet financial system. From inception, we have been deeply focused on being trusted, transparent, compliant, ethical and well governed. Holding ourselves to the high standards of the NYSE and SEC rules and regulations further deepens those attributes.    To every single person, project and firm who’s been part of this journey, thank you.  I am humbled and deeply grateful.  This is not only a moment for each of us personally, I believe it's a significant moment in the future development of our global economic system as it inexorably synthesizes with the internet.

1/8 Big news from Catena Labs! We've secured $18M in funding, led by @a16zcrypto, to build an AI-native financial institution. Why? Because traditional financial systems are unprepared and resistant to AI, hindering the growth of the agent economy.

Just 5 days left to apply to the 11th cohort of Frequency Bio! In partnership with @mdplus__, we're helping doctors, residents & med students explore launching biotech startups — free & flexible, on your terms. Apply below👇 frequency.pillar.vc

Great to see @RowanSci highlighted by @scalevp alongside folks like @EvoscaleAI, @IsomorphicLabs, @chaidiscovery, & @schrodinger. "Success... will be contingent on providing step change capabilities vs. whatever is available as a commodity in open-source." We totally agree!

🏆 @TIME names @ShivdevRao to the 𝗧𝗜𝗠𝗘𝟭𝟬𝟬 𝗛𝗲𝗮𝗹𝘁𝗵 list as one of the leaders shaping the future of health with AI. This recognition from TIME is a testament to Abridge partners, their clinicians, and their pioneering spirit: time.com/collections/ti…

Today at @RowanSci, we're releasing Egret-1, a family of open-source neural network potentials. On lots of benchmarks, the Egret-1 models match or exceed the accuracy of quantum chemistry for organic & biomolecular simulation. Here's me and @manntis4 with a brief video intro: